{
  "pmcid": "12304718",
  "sha256": "bca33c95c8b09607675efb31b44d408adeea62617213e4ecc682195453f8e094",
  "timestamp_utc": "2025-11-09T23:32:37.500521+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.159243190661481,
    "reading_ease": 23.60470136186774,
    "word_count": 257
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tranexamic Acid in Total Hip Arthroplasty"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This double-blind, randomised controlled trial included 50 patients undergoing primary THA at Thomas Jefferson University Hospital from April 2019 to December 2021."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were aged 18–85 years, ASA Physical Status 1–3."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomised 1:1 to receive either TXA (10 mg/kg) or placebo (0.9% sodium chloride)."
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesized no difference in fibrinolysis and blood loss between TXA and placebo."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was fibrinolysis, defined as maximum lysis (ML) >15% within 1 hour, measured by rotational thromboelastometry (ROTEM)."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used a permuted block design, with allocation concealed by opaque envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, surgeons, and assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "This double-blind, randomised controlled trial included 50 patients undergoing primary THA at Thomas Jefferson University Hospital from April 2019 to December 2021."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "22 patients received TXA and 25 received placebo."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No significant differences in clinical outcomes, including blood loss and coagulation profiles, were observed."
      },
      "Harms": {
        "score": 1,
        "evidence": "Two thrombotic events occurred in the placebo group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03897621."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Department of Anesthesiology, Thomas Jefferson University Hospital."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}